|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
2
|
Esserman L: Integration of imaging in the
management of breast cancer. J Clin Oncol. 23:1601–1602. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Groheux D, Giaccchetti S, Espié M, et al:
The yield of 18F-FDG PET/CT in patients with clinical
stage IIA, IIB, or IIIA breast cancer: a prospective study. J Nucl
M. 52:1526–1534. 2011.
|
|
4
|
Groheux D, Moretti J, Baillet G, et al:
Effect of 18F-FDG PET/CT imaging in patients with
clinical stage II and III breast cancer. Int J Radiat Oncol Biol
Phys. 71:695–704. 2008.
|
|
5
|
Heusner TA, Kuemmel S, Umutlu L, et al:
Breast cancer staging in a single session: whole-body PET/CT
mammography. J Nucl Med. 49:1215–1222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fuster D, Duch J, Paredes P, et al:
Preoperative staging of large primary breast cancer with
[18F] fluorodeoxyglucose positron emission
tomography/computed tomography compared with conventional imaging
procedures. J Clin Oncol. 26:4746–4751. 2008.
|
|
7
|
Aukema TS, Straver ME, Peeters MJ, et al:
Detection of extra-axillary lymph node involvement with FDG PET/CT
in patients with stage II–III breast cancer. Eur J Cancer.
46:3205–3210. 2010.PubMed/NCBI
|
|
8
|
Segaert I, Mottaghy F, Ceyssens S, et al:
Additional value of PET-CT in staging of clinical stage IIB and III
breast cancer. Breast J. 16:617–624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th edition).
Springer. New York: 2010.
|
|
10
|
Nakamoto Y, Cohade C, Tatsumi M, Hammoud D
and Wahl RL: CT appearance of bone metastases detected with FDG PET
as part of the same PET/CT examination. Radiology. 237:627–634.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Quon A and Gambhir SS: FDG-PET and beyond:
molecular breast cancer imaging. J Clin Oncol. 23:1664–1673. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heusner TA, Kuemmel S, Hahn S, et al:
Diagnostic value of full-dose FDG-PET/CT for axillary lymph node
staging in breast cancer patients. Eur J Nucl Med Mol Imaging.
36:1543–1550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Groheux D, Hindié E, Rubello D, et al:
Should FDG PET/CT be used for initial staging of breast cancer? Eur
J Nucl Med Mol Imaging. 36:1539–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JH, Rosen EL and Mankoff DA: The role
of radiotracer imaging in the diagnosis and management of patients
with breast cancer: part 1 – overview, detection, and staging. J
Nucl Med. 50:569–581. 2009.
|
|
15
|
Yang WT, Le-Petross HT, Macapinlac H, et
al: Inflammatory breast cancer: PET/CT, MRI, mammography, and
sonography findings. Breast Cancer Res Treat. 109:417–426. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carkaci S, Macapinlac HA, Cristofanilli M,
et al: Retrospective study of 18F FDG PET/CT in the
diagnosis of inflammatory breast cancer: preliminary data. J Nucl
Med. 50:231–238. 2009.
|
|
17
|
Kuru B, Camlibel M, Dinc S, Gulcelik MA
and Alagol H: Prognostic significance of axillary node and
infraclavicular lymph node status after mastectomy. Eur J Surg
Oncol. 29:839–844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brito RA, Valero V, Buzdar AU, et al:
Long-term results of combined-modality therapy for locally advanced
breast cancer with ipsilateral supraclavicular metastases: The
University of Texas M.D. Anderson Cancer Center experience. J Clin
Oncol. 19:628–633. 2001.
|
|
19
|
Cermik TF, Mavi A, Basu S and Alavi A:
Impact of FDG PET on the preoperative staging of newly diagnosed
breast cancer. Eur J Nucl Med Mol Imaging. 35:475–483. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Port ER, Yeung H, Gonen M, et al:
18F-2-fluoro-2-deoxy-D-glucose positron emission
tomography scanning affects surgical management in selected
patients with high-risk, operable breast carcinoma. Ann Surg Oncol.
13:677–684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahner S, Schirrmacher S, Brenner W, et
al: Comparison between positron emission tomography using
2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and
computed tomography for staging of breast cancer. Ann Oncol.
19:1249–1254. 2008.
|
|
22
|
Nakai T, Okuyama C, Kubota T, et al:
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone
metastases in patients with breast cancer. Eur J Nucl Med Mol
Imaging. 32:1253–1258. 2005. View Article : Google Scholar : PubMed/NCBI
|
